| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 05/06/2004 | WO2003082853A8 New compounds |
| 05/06/2004 | WO2003051837A8 Tetrahydrocarbozole derivatives as ligands for g-protein coupled receptors (gpcr) |
| 05/06/2004 | WO2003040096A3 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 05/06/2004 | WO2001029710A3 Derivative domain names |
| 05/06/2004 | US20040087802 Process for preparing glycidylphthalimide |
| 05/06/2004 | US20040087798 Novel amide compounds |
| 05/06/2004 | US20040087796 Substituted carbazoles as inhibitors of spla2 |
| 05/06/2004 | US20040087637 Antiserotonine agents; central nervous system disorders |
| 05/06/2004 | US20040087627 Decarboxylase inhibitors; cardiovascular diosrders; antidiabetic agents; anticancer agents; dietetics |
| 05/06/2004 | US20040087625 Dietetics; antilipemic agents; anticholesterol agents; reducing triglycerides |
| 05/06/2004 | US20040087624 Analgesics; antiinflammatory agents; immunology; bone disorders; neurodegradation diseases |
| 05/06/2004 | US20040087623 Pyrazole derivatives against tgf overexpression |
| 05/06/2004 | US20040087620 Terphenyl compounds bearing substituted amino groups |
| 05/06/2004 | US20040087595 1-aryl- or 1-alkylsulfony-heterocyclybenzazoles as 5-hydroxytryptamine-6 ligands |
| 05/06/2004 | US20040087593 4-Piperazinyl benzenesulfonyl indoles and uses thereof |
| 05/06/2004 | US20040087585 Peptide deformylase inhibitors |
| 05/06/2004 | US20040087568 Substituted anthranilic amide derivatives and methods of use |
| 05/06/2004 | US20040087548 Anticancer agents and treating immune disorders |
| 05/06/2004 | US20040087491 Electrophilic ketones for the treatment of herpesvirus infections |
| 05/06/2004 | EP1416017A1 Fluorescent nucleosides, nucleotides or polynucleotides containing a rhodamine dye |
| 05/06/2004 | EP1415992A1 Diamine derivatives |
| 05/06/2004 | EP1415986A1 Spiro compounds |
| 05/06/2004 | EP1415985A1 Process for producing optically active azetidine-2-carboxylic acid |
| 05/06/2004 | EP1415666A1 Medicinal compositions for opthalmic use |
| 05/06/2004 | EP1414817A1 Substituted isoindoles and e use thereof |
| 05/06/2004 | EP1414806A1 Novel vinyl n-(2-benzoylphenyl)-l-tyrosine derivatives and their use as antidiabetics etc |
| 05/06/2004 | EP1414805A1 Indazole or indole derivatives, their use in human medicine and more particularly in cancerology |
| 05/06/2004 | EP1414797A2 Hepatitis c virus polymerase inhibitors with a heterobicylic structure |
| 05/06/2004 | EP1414795A1 Bicyclic modulators of androgen receptor function |
| 05/06/2004 | EP1414792A1 Fluoro linkers and their use as linkers for enzyme-activated drug conjugates |
| 05/06/2004 | EP1414788A1 Naphthylurea and naphthylacetamide derivatives as vanilloid receptor 1 (vr1) antagonists |
| 05/06/2004 | EP1414442A1 3-arylsulfonyl-7-piperazinyl- indoles, -benzofurans and -benzothiophenes with 5-ht6 receptor affinity for treating cns disorders |
| 05/06/2004 | EP1414441A2 Hepatitis c virus polymerase inhibitors with heterobicyclic structure |
| 05/06/2004 | EP1140826B1 Method for producing (2s,4r,9s)-octahydro-1h-indole-2-carboxylic acid and intermediate products therefor |
| 05/06/2004 | EP0968182B1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 05/06/2004 | EP0835115B1 4-(2-(n-2-carboxamidoindole)aminoethyl)-benzenesulfonamides or sulfonylureas as pdgf antagonists |
| 05/06/2004 | CA2503015A1 Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 05/06/2004 | CA2501228A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 and type 2 |
| 05/06/2004 | CA2498215A1 Oxindole substituted piperazine derivatives |
| 05/05/2004 | CN1148368C Preparation of asymmetric cyanine dyes for DVD-R CD |
| 05/05/2004 | CN1148355C Pyridazin-3-one derivatives and medicines containing the same |
| 05/05/2004 | CN1148346C Hydrazine derivs. |
| 05/05/2004 | CN1148183C Indoly-3-glyoxylic acid derivatives with antitumoral activity |
| 05/04/2004 | US6730794 Substituted indolealkanoic acids |
| 05/04/2004 | US6730783 Reacting aminoguanidine with carbonyl compound to form amidinohydrazone; reduction; reacting with alkoxyamine; guanidinylation; anticoagulants |
| 05/04/2004 | US6730705 Alkoximino acetic acid amides |
| 05/04/2004 | US6730695 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for V1b and V1a arginine-vasopressin receptors |
| 05/04/2004 | US6730684 Key regulatory point in the overall synthetic pathway of bacterial fatty acid biosynthesis; fabi is an ideal target for antibacterial intervention |
| 05/04/2004 | US6730419 Blue light emitting compound and organic electroluminescent device employing the same as color developing substance |
| 05/04/2004 | US6730326 Carvedilol can be isolated in two polymorphic forms that are monotropic depending upon the method of preparation which are distinguishable by their infra-red raman and x-ray powder diffraction spectra, and their melting points. |
| 04/29/2004 | WO2004035736A2 Halogenated selective androgen receptor modulators and methods of use thereof |
| 04/29/2004 | WO2004035571A1 Substituted indoles and their use as hcv inhibitors |
| 04/29/2004 | WO2004035556A1 Substituted piperazines, (1,4) diaszepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists |
| 04/29/2004 | WO2004035525A1 Inhibitors of histone deacetylase |
| 04/29/2004 | WO2004022712A3 INDOLE-TYPE DERIVATIVES AS INHIBITORS OF p38 KINASE |
| 04/29/2004 | WO2004006354A3 Polymeric charge transport compositions and electronic devices made with such compositions |
| 04/29/2004 | WO2003104282A8 Glycoprotein vi - fc fusion protein for treating vascular disorders |
| 04/29/2004 | WO2003086282A3 Nitric oxide donors, compositions and methods of use |
| 04/29/2004 | WO2002078626A3 Therapeutic combinations for cardiovascular and inflammatory indications |
| 04/29/2004 | US20040082786 Piperazine based inhibitors of factor xa |
| 04/29/2004 | US20040082785 Process for making an aldehyde |
| 04/29/2004 | US20040082783 Bis (amino acid) molecular scaffolds |
| 04/29/2004 | US20040082780 Vanilloid receptor ligands and their use in treatments |
| 04/29/2004 | US20040082778 Amination process |
| 04/29/2004 | US20040082663 Imidazoline receptor binding compounds |
| 04/29/2004 | US20040082652 Nitric ester derivatives and their use in treating gastrointestinal tumors |
| 04/29/2004 | US20040082635 Fused cyclic compounds and medicinal use thereof |
| 04/29/2004 | US20040082628 Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 04/29/2004 | US20040082625 Osteoporosis, bone disorders |
| 04/29/2004 | US20040082615 Psychological disorders; central nervous system disorders |
| 04/29/2004 | US20040082603 2,3-Dihydro-isoindol-1-one derivatives |
| 04/29/2004 | US20040082601 Anti-inflammatory compounds |
| 04/29/2004 | US20040082594 Novel uses of combined 5-ht 1a agonists and serotonin reuptake inhibitors |
| 04/29/2004 | US20040082590 Dietetics; antidiabetic agents; sexual disorders |
| 04/29/2004 | US20040082575 Compounds and methods for modulation of estrogen receptors |
| 04/29/2004 | US20040082547 Prevent thrombosis; anticholesterol agents; cardiovascular disorders; anticancer agents |
| 04/29/2004 | US20040082496 For the treatment of body weight disorders (obesity/anorexia/ bulemia/cachexia) |
| 04/29/2004 | US20040081622 Absorption, fluorescence of light; diagnosis of kidney, heart diseases |
| 04/29/2004 | CA2588083A1 Selective androgen receptor modulators and methods of use thereof |
| 04/29/2004 | CA2502355A1 Halogenated selective androgen receptor modulators and methods of use thereof |
| 04/29/2004 | CA2502249A1 Substituted piperazines, (1,4) diaszepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists |
| 04/29/2004 | CA2501547A1 Substituted indoles and their use as hcv inhibitors |
| 04/29/2004 | CA2501265A1 Inhibitors of histone deacetylase |
| 04/28/2004 | EP1413302A2 Substituted guanidines for the treatment of pain |
| 04/28/2004 | EP1412515A2 Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase antagonists |
| 04/28/2004 | EP1412364A1 Platelet adp receptor inhibitors |
| 04/28/2004 | EP1412336A1 Peptoid compounds |
| 04/28/2004 | EP1412335A2 ENANTIOSELECTIVE TRANSFORMATION OF $g(a), $g(b)-UNSATURATED ALDEHYDES USING CHIRAL ORGANIC CATALYSTS |
| 04/28/2004 | EP1412327A2 Inhibitors of protein kinase for the treatment of disease |
| 04/28/2004 | EP1412317A1 Retinoid derivatives with antiangiogenic, antitumor and proapoptotic activities |
| 04/28/2004 | EP1412028A1 Tetrahydroindolone and purine derivatives linked to arylpiperazines |
| 04/28/2004 | EP1411940A1 Bridged piperidine derivatives as melanocortin receptor agonists |
| 04/28/2004 | EP1411925A1 5-arylsulfonyl indoles having 5-ht6 receptor affinity |
| 04/28/2004 | EP1222168B1 Slurry preparation of bis(halophthalimides) and of polyether polymers |
| 04/28/2004 | EP1135124B1 Antihypertriglyceridemic, antihyperglycemic, anti-angiogenic and wound healing substituded indolealkanoic acids |
| 04/28/2004 | EP0585366B1 Using allosteric hemoglobin modifiers to decrease oxygen affinity in blood |
| 04/28/2004 | EP0558648B1 Improved matrix metalloprotease inhibitors |
| 04/28/2004 | CN1491941A Heterobicyclic sulfonamide derivative and sulfonic ester derivative |
| 04/28/2004 | CN1147486C 4-and 5-alkynyloxindoles and 4-and 5-alkenyloxindoles |
| 04/28/2004 | CN1147470C Novel 2,3,3A,4,9,9A hexahydro-8-hydroxy-1H-benz[f] indoles, a method for the production thereof, and their use as medicine |